150
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serological Biomarker-Based Machine Learning Models for Predicting the Relapse of Ulcerative Colitis

, , ORCID Icon, , ORCID Icon &
Pages 3531-3545 | Received 26 May 2023, Accepted 11 Aug 2023, Published online: 21 Aug 2023

References

  • Wang R, Li Z, Liu S, et al. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023;13(3):e065186.
  • M’Koma AE. Inflammatory bowel disease: clinical diagnosis and pharmaceutical management. Med Res Arch. 2023;11(1). doi:10.18103/mra.v11i1.3135
  • Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770.
  • Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19:1079–1087.
  • Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965–990.
  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies [published correction appears in Lancet. Lancet. 2020;396(10256):e56].
  • Chen P, Zhou G, Lin J, et al. Serum Biomarkers for Inflammatory Bowel Disease. Front Med. 2020;7:123.
  • Høie O, Aamodt G, Vermeire S, et al. Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohns Colitis. 2008;2(2):114–122.
  • Pang Y, Ruan H, Wu D, et al. Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis. Allergy Asthma Clin Immunol. 2020;16:37.
  • Singh S, Ananthakrishnan AN, Nguyen NH, et al. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology. 2023;164(3):344–372.
  • Ma L, Pang X, Ji G, et al. Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis: a meta-analysis and systematic review. Medicine. 2021;100(42):e27551.
  • Plevy S, Silverberg MS, Lockton S, et al. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn’s disease, and ulcerative colitis patients. Inflamm Bowel Dis. 2013;19(6):1139–1148.
  • Wang T, Yu W, Wu F, Zhang Y, Shang J, Zhao Z. Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: a Retrospective Study. Front Oncol. 2022;12:914092.
  • Chen W, Zhang L, Cai G, et al. Machine learning-based multimodal MRI texture analysis for assessing renal function and fibrosis in diabetic nephropathy: a retrospective study. Front Endocrinol (Lausanne). 2023;14:1050078.
  • Hadi F, Sumarsono B, Lee KS, et al. A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study. Neurourol Urodyn. 2023. doi:10.1002/nau.25190
  • Feng C, Di J, Jiang S, et al. Machine learning models for prediction of invasion Klebsiella pneumoniae liver abscess syndrome in diabetes mellitus: a singled centered retrospective study. BMC Infect Dis. 2023;23(1):284.
  • Li H, Lai L, Shen J. Development of a susceptibility gene based novel predictive model for the diagnosis of ulcerative colitis using random forest and artificial neural network. Aging. 2020;12(20):20471–20482.
  • Bamber JH, Evans SA. The value of decision tree analysis in planning anaesthetic care in obstetrics. Int J Obstet Anesth. 2016;27:55–61.
  • Kriegeskorte N, Golan T. Neural network models and deep learning. Curr Biol. 2019;29(7):R231–R236.
  • Zhao M, Gönczi L, Lakatos PL, et al. The Burden of Inflammatory Bowel Disease in Europe in 2020. J Crohns Colitis. 2021;15(9):1573–1587.
  • Yuan W, Marwaha JS, Rakowsky ST, et al. Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: a Nationwide Retrospective Analysis. Inflamm Bowel Dis. 2023;29(5):695–704.
  • Kraszewski S, Szczurek W, Szymczak J, et al. Machine Learning Prediction Model for Inflammatory Bowel Disease Based on Laboratory Markers. Working Model in a Discovery Cohort Study. J Clin Med. 2021;10(20):4745.
  • Bolander A, Agnarsdóttir M, Wagenius G, et al. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma. Melanoma Res. 2008;18(6):412–419.
  • Ou Z, Mao W, Tan L, et al. Prediction of Postoperative Pathologic Risk Factors in Cervical Cancer Patients Treated with Radical Hysterectomy by Machine Learning. Curr Oncol. 2022;29(12):9613–9629.
  • Kurimoto N, Nishida Y, Hosomi S, et al. Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing. PLoS One. 2023;18(1):e0280252.
  • Nishida Y, Hosomi S, Yamagami H, et al. Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction. PLoS One. 2019;14(3):e0213505.
  • Furukawa S, Yagi S, Shiraishi K, et al. Association between platelet count and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study. BMC Gastroenterol. 2020;20(1):384.
  • Nakarai A, Kato J, Hiraoka S, et al. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count. World J Gastroenterol. 2014;20(48):18367–18374.
  • Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut. 2001;49(5):671–677.
  • Li Y, Zhang YY, Yang LT, et al. FcγRI plays a critical role in patients with ulcerative colitis relapse. Eur J Immunol. 2021;51(2):459–470.
  • Mookhoek A, Haasnoot ML, Bredenoord AJ, et al. The Clinical Significance of Eosinophils in Ulcerative Colitis: a Systematic Review. J Crohns Colitis. 2022;16(8):1321–1334.
  • Li H, Mo Y, Huang C, et al. An MSCT-based radiomics nomogram combined with clinical factors can identify Crohn’s disease and ulcerative colitis. Ann Transl Med. 2021;9(7):572.
  • Wu F, Zhang Y, Cui W, et al. Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy. Sci Rep. 2021;11(1):18064.
  • James C, Ranson JM, Everson R, et al. Performance of Machine Learning Algorithms for Predicting Progression to Dementia in Memory Clinic Patients. JAMA Netw Open. 2021;4(12):e2136553.
  • Chiofolo C, Chbat N, Ghosh E, et al. Automated Continuous Acute Kidney Injury Prediction and Surveillance: a Random Forest Model. Mayo Clin Proc. 2019;94(5):783–792.
  • Hong W, Lu Y, Zhou X, et al. Usefulness of Random Forest Algorithm in Predicting Severe Acute Pancreatitis. Front Cell Infect Microbiol. 2022;12:893294.
  • Sammut SJ, Crispin-Ortuzar M, Chin SF, et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature. 2022;601(7894):623–629.
  • Chen KA, Joisa CU, Stem JM, et al. Prediction of Ureteral Injury During Colorectal Surgery Using Machine Learning. Am Surg. 2023;31348231173981.
  • Hasannejadasl H, Osong B, Bermejo I, et al. A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer. Front Oncol. 2023;13:1168219.